News

IVF on public insurance: China study finds ART pregnancies rose. Could India follow?

Infographic: China added ART to public insurance in Guangxi and ART pregnancies rose; in India IVF isn't covered by PM-JAY and a cycle costs about Rs 1.1 to 2.3 lakh.

· IVF Automation News

Summary

A peer-reviewed study published on 2 November 2026 found that pregnancies achieved through assisted reproduction rose in China’s Guangxi region after a range of ART procedures were added to public health insurance in November 2023. The share of multiple pregnancies did not change. In India, IVF is not covered by the national PM-JAY scheme and families pay an estimated ₹1.10 lakh to ₹2.30 lakh per cycle out of pocket, so the findings are a useful signal of what wider coverage could do to clinic demand.

The Guangxi researchers start from a simple point: ART is effective but underused because of its high cost. China has been testing what happens when the state pays part of the bill, and province-level evidence is starting to appear. For clinic owners and lab managers in India, the question is less “will this happen here?” and more “would our lab cope if it did?”

What did the Guangxi study find?

Researchers from Peking University and partner institutions analysed aggregated insurance claims from the Guangxi Healthcare Security Administration from January 2022 to July 2024. That gave them 22 months before the policy and 9 months after it. They identified ART pregnancies through ICD-10 codes and used an interrupted time series design, which tests whether a trend changes after a specific event. Non-ART pregnancies served as a comparison series.

The authors conclude that, in the short term, coverage improved access to ART and equity of access in a resource-constrained province.

What are the limits of this evidence?

The study measured pregnancies, not live births. It covers one region and only nine months after the policy started, and it uses aggregated claims rather than patient records, so it cannot show cycle numbers, success rates per cycle or costs to clinics. We reviewed the published abstract; the absolute monthly figures behind the reported effect sizes were not in it, so we do not quote them.

How far has China gone with IVF coverage?

Guangxi was not alone. China’s National Healthcare Security Administration said that by 30 October 2024, 27 provinces and the Xinjiang Production and Construction Corps had issued policies bringing assisted reproduction into medical insurance reimbursement, with Guangxi on that list. The notice also cites a State Council General Office document of 19 October 2024 that tells local governments to include “suitable” ART services in insurance. What is covered, and at what rate, varies by province.

Where does India stand?

In a written Lok Sabha reply reported on 13 February 2026, Minister of State for Health Prataprao Jadhav said the Centre does not cover ART, including IVF, under Ayushman Bharat PM-JAY. He cited a Health Technology Assessment India estimate from ICMR-NIRRCH that the average out-of-pocket cost of one IVF cycle is about ₹1.10 lakh in public hospitals and ₹2.30 lakh in private hospitals. He pointed to two narrower schemes: the Jiyo Parsi programme, and Sikkim’s Vatsalya Yojana, which offers up to ₹3 lakh for IVF.

The need is large. The World Health Organization estimated in 2023 that about 17.5% of adults, roughly 1 in 6 people, experience infertility in their lifetime.

What does this mean for embryologists, lab managers and clinic owners?

Any move to fund IVF in India, whether a state scheme, an employer benefit or a future change to PM-JAY, would likely raise cycle volumes. The Guangxi data point to three practical lessons:

  1. Capacity is the bottleneck. A sudden jump in cycles lands on the embryology lab, not the front desk. Labs that already track workload and key performance indicators can see strain early. Our guide to IVF lab KPI dashboards explains how.
  2. Smaller towns may move fastest. In Guangxi, the biggest immediate gains came where there were few ART facilities. In India, that would favour clinics and chains already present in tier 2 and tier 3 cities.
  3. Payers want paperwork. Insurance-funded cycles come with audits. Clean consent, witnessing and outcome records, which the ART Act already requires, become a billing asset. See our ART Act lab compliance checklist and witnessing guide.

What is the commercial outlook?

For now, India has no national plan to cover IVF, and nothing in this study changes that. But the direction in China is clear, and policy debate in India is active, as the Lok Sabha question shows. Clinic groups that can scale lab capacity without losing quality, and suppliers of automation and lab software that make that scaling auditable, would be best placed if public or employer funding grows. We will update this story if Indian policy moves.

This article reports research and policy. It is not medical, financial or legal advice.

Sources

  1. Lyu C, Zhao Q, Wang Y, He Y, Xu J. “Short-term Effects of Social Health Insurance Coverage of Assisted Reproductive Technologies on Pregnancies in Guangxi, China: An Interrupted Time Series Study”, International Journal of Health Policy and Management, published 2 Nov 2026 (peer-reviewed; abstract reviewed). https://www.ijhpm.com/article_4955.html
  2. National Healthcare Security Administration of China, “27 provinces and the Xinjiang Production and Construction Corps have included assisted reproduction in medical insurance” (in Chinese), 30 Oct 2024 (official notice). https://www.nhsa.gov.cn/art/2024/10/30/art_14_14465.html
  3. Kavita Bajeli-Datt, “IVF not covered under PM-JAY: Minister Prataprao Jadhav in Lok Sabha”, The New Indian Express, 13 Feb 2026 (news report of a written parliamentary reply). https://www.newindianexpress.com/india/2026/Feb/13/ivf-not-covered-under-pm-jay-minister-prataprao-jadhav-in-lok-sabha
  4. World Health Organization, “1 in 6 people globally affected by infertility: WHO”, 4 Apr 2023 (news release). https://www.who.int/news/item/04-04-2023-1-in-6-people-globally-affected-by-infertility

Tags: IVF insurance coverage, assisted reproduction insurance China, Guangxi, social health insurance, ART pregnancies, PM-JAY IVF, IVF cost India, IVF lab capacity

Get IVF Automation Weekly

The week's verified IVF industry news in your inbox.